ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q4Scopus Q3SCImago #22,830Hybrid

Acta Poloniae Pharmaceutica

Abbreviation (ISO):ACTA POL PHARM
•
Identifier (ISSN):0001-6837(Print)
•
Publisher:Polish Pharmaceutical Society
Clarivate IF (2026)
0.6↑ +0.2
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Acta Poloniae Pharmaceutica

WoS Q4
00110.5320180.4520190.4620200.3320210.5620220.420230.420240.420250.62026
Annual Impact Factor Metric
Current (2026):0.6
Scopus SJR & RankScopus Q3
0.186
#22,830

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
55

55 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate25%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
87articles/year
97.79% Gold OA•88.89% Original Research

Aims & Scope

The international journal of the Polish Pharmaceutical Society is published in 6 issues a year. The journal offers Open Access publication of original research papers, short communications and reviews written in English, in all areas of pharmaceutical sciences. The following areas of pharmaceutical sciences are covered: Analysis, Biopharmacy, Drug Biochemistry, Drug Synthesis, Natural Drugs, Pharmaceutical Technology, Pharmacology and General. A bimonthly appearing in English since 1994, which continues “Acta Poloniae Pharmaceutica”, whose first issue appeared in December 1937. The war halted the activity of the journal’s creators. Issuance of “Acta Poloniae Pharmaceutica” was resumed in 1947. From 1947 the journal appeared irregularly, initially as a quarterly, then a bimonthly. In the years 1963 – 1973 alongside the Polish version appeared the English edition of the journal. Starting from 1974 only works in English are published in the journal. Since 1995 the journal has been appearing very regularly in two-month intervals (six books a year). The journal publishes original works from all fields of pharmacy, summaries of postdoctoral dissertations and laboratory notes.

Topics Covered (Recognized by AI)
Chemistry93.1%Biology82.4%Medicine63.4%Organic chemistry63.2%Biochemistry56%Internal medicine36.7%Genetics34.5%Pharmacology32.9%Physics32.6%Chromatography31.7%Endocrinology21%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q4
Rank342/356
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q4
Rank343/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF0.6
Articles / Year24
Total Citations0
2025
IF0.4
Articles / Year84
Total Citations8
2024
IF0.4
Articles / Year73
Total Citations57
2023
IF0.4
Articles / Year105
Total Citations116
2022
IF0.555
Articles / Year89
Total Citations133

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #22,830Scopus Q3SCImago Profile
Scopus Coverage:1951-1955, 1961-2025
Scopus Broad Areas:Pharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q3
0.186

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
0.62

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,385 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations144
3-Year Documents263
Citable Documents262

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate57.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmaceutical ScienceQ3
PharmacologyQ4
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 25%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Acta Poloniae Pharmaceutica (abbr: ACTA POL PHARM, ISSN: 0001-6837) is a peer-reviewed international scholarly journal in the field of Medicine, published by Polish Pharmaceutical Society in Poland since 1937. The periodical holds a Journal Impact Factor (JIF) of 0.60, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.186 (Q3), an H-index of 55.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 87 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,385 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Polish Pharmaceutical Society
Publication Language
English
Frequency
Quarterly
Founding Year
1937
Indexing & Databases
SCIEScopusPubMed
Editorial Address
POLSKIEGO TOWARZYSTWA FARMACEUTYCZNEGO, DLUGA 16, WARSAW, POLAND, 00-238

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: c55c5c45-6552-4f33-b7d6-f218e60030cf
Database Updated: 2026-10-01